Delivery Order SPE2DB22D3301-SPE2DB24FX6AA
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,405.34 firm fixed-price delivery order is for PIPERACIL-TAZOBACT 4.5 GM VIALS, a pharmaceutical product. The contract has a period of performance through November 15, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,745.83 firm fixed-price delivery order is for PIPERACIL-TAZOBACT 3.375 GM VLS, a pharmaceutical product, with a completion date of February 21, 2025. The award is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,623.27 firm-fixed-price delivery order is for PIPERACIL-TAZOBACT 3.375 GM VLS, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,768.55 firm fixed-price delivery order is for the supply of Piperacil-Tazobact 3.375 GM VLS, a medical product, with a performance period through March 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of Piperacil-Tazobact 4.5 GM vials, a type of antibiotic medication. The contract is a Delivery Order with a Firm Fixed Price of $1,916.25 and has an Ultimate Completion Date of July 18, 2025. The contract is not set aside and was competitively awarded....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,767.92 Firm Fixed Price delivery order is for the supply of Piperacil-Tazobact 3.375 gm vials. The contract has an ultimate completion date of June 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of PIPERACIL-TAZOBACT 4.5 GM VIALS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $1,615.41 and an Ultimate Completion Date of July 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Piperacillin-Tazobactam 4.5 GM vials, a critical antibiotic medication, with a ceiling value of $1,407.70 and a period of performance through February 24, 2025. The contract is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- This federal contract award is a delivery order valued at $1,187.72 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 4,563,859,262 units of the drug PIPERACIL-TAZOBACT 4.5 GM VIALS to support military treatment programs and facilities. The contract is a firm fixed price award with a completion date of March 6, 2024. Amerisourcebergen Drug Corp serves as...
- This federal contract award is a delivery order (SPE2DX15D1022|SPE2DX25FUYNC) valued at $4,318.92 for the supply of the pharmaceutical product Piperacil-Tazobact 3.375 GM VLS. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp, Corporate Office Division. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX6AADelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,246.83 firm fixed-price delivery order is for the supply of 4.5 gram vials of the antibiotic piperacillin-tazobactam. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order falls under that larger IDC. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 11/28/23 |